From somatic mutations to Quotient

2024-07-05T10:10:12+01:0021 November 2023|

We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.